Spatiotemporal control of cyclic AMP immunomodulation through the PKA-Csk inhibitory pathway is achieved by anchoring to an Ezrin-EBP50-PAG scaffold in effector T cells.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples